- Facial Feminization Surgery: Private, Personal Identity, Compensatory Justice, and Resource Allocation
- Facial Feminization Surgery: Privacy, Personal Identity, Compensatory Justice, and Resource Allocation
- The Democratization of Facial Feminization Surgery and the Removal of Artificial Barriers
- Is CRISPR Different? Considering Exclusivity for ResearchTools, Therapeutics, and Everything In Between
- The Biopolitics of Passing and the Possibility of Radically Inclusive Transgender Health Care
- Extending Health Insurance for Body Modifications for Gender Transitions
- Patenting in the Public Interest: The California Institute for Regenerative Medicine Model
- In Favor of Covering Ethically Important Cosmetic Surgeries: Facial Feminization Surgery for Transgender People
- Foundational Technologies and Accountability
- Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies
- A Queer, Feminist Bioethics Critique of Facial Feminization Surgery
- Faces Matter
- Sunset on the RAC: When Is It Time to End Special Oversight of an Emerging Biotechnology?
- Gene Patents and the Social Justice Lens
- ‘Medical Necessity’ and Domination
- Laying the Foundation for Foundational Technologies
- The View of CRISPR Patents Through the Lens of Solidarity and the Public Good
- Fair Governance of Biotechnology: Patents, Private Governance, and Procedural Justice
- The Human Right to Science and Foundational Technologies
- Facial Feminization Surgery in Gender Dysphoria Should Be Reimbursed Like Genital Surgery, but the Main Problem Lies Elsewhere
- Accepting Things at Face Value: Insurance Coverage for Transgender Health Care
- Foundational Technologies and Legal Realities
- Acknowledging the Transition Spectrum
- From Interest to Applause to Despair
- CRISPR Patents: Aspiring to Coherent Patent Policy
- Facial Feminization Surgery: The Ethics of Gatekeeping in Transgender Health
- Family Ethics and Public Policy: Beyond the Medical Model
- Response to Commentaries on “Shrinking Poor White Life Spans”
- Asymmetrical Intuitions
- Health Research Priority Setting: A Duty to Maximize Social Value?
- Priority Setting Is More Than Resource Allocation: Reflecting on the Content of Funders’ Duties and Their Implications for Current Practice
- Conceptual, Structural, and Practical Challenges to Ethical Allocation of Research Funds
- Acquired Duties for Ethical Research With American Indian/Alaska Native Populations: An Application of Pierson and Millum’s Framework
- Public Health Disaster-Related Research: A Solidaristic Ethical Prism for Understanding Funders’ Duties
- The Epigenetic Imperative: Responsibility for Early Intervention at the Time of Biological Plasticity
- Aligning Research Priorities to Improve Equity: A Challenge for Health Funders
- Universal Funder Responsibilities That Advance Social Value
- One Health, Bioethics, and Nonhuman Ethics
- Just Ethics? Bioethical Prescriptions for Policymakers Should Remain Communal
- Distinguishing Primary and Secondary Early Intervention Programs: Implications for Families, Clinicians, and Policymakers
- Is There a Business Case for Constitutive Duties of For-Profit Research Funders?
- Beyond Parenting: The Responsibility of Multidisciplinary Health Care Providers in Early Intervention Policy Guidance
- Health Research Priority Setting: The Duties of Individual Funders
- Practical Problems Related to Health Research Funding Decisions
- Pfizer’s Corporate Citizenship
- Health Research Priority Setting: State Obligations and the Human Right to Science
- Just Policy? An Ethical Analysis of Early Intervention Policy Guidance
- Retribution, Reparation, and the Moral Claims of Communities
- The Racist Underbelly of Health Disparities in America
- Responsibility for Poor Health Status of Lower Income People Must Account for Morally Blameworthy Decisions Made by Employers Who Exploit Them
- A Human Rights Approach to Health Disparities
- Response to Open Peer Commentaries on “The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine”
- Engaging the Uncertainties of Ebola Outbreaks: An Anthropo-Ecological Perspective
- Blinds and Research Risks
- Social Reproductive Labor, Gender, and Health Justice
- Vaccines, Apes, and Conspiracy
- It Is Past Time to Think More Inclusively About “Deaths of Despair”
- A Crisis of Identity, a Crisis of Place
- Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective
- An Experimental Ethics, but an Ethical Experiment? Anthropological Perspectives on Using Unproven Vaccines on Endangered Primates
- Rapamycin: Risking Harm for Canine Longevity
- Companion Animal Studies: Slipping Through a Research Oversight Gap
- A Radical Approach to Ebola: Saving Humans and Other Animals
- Shrinking Poor White Life Spans: Class, Race, and Health Justice
- Floating All Boats: Promoting Solidarity to Advance Social Justice
- Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials
- The Scientific and Social Implications of Unblinding a Study Subject
- Instilling Fairness in Animal Research
- The One Health Approach to Zoonotic Emerging Infectious Diseases
- A Randomized Trial of Rapamycin to Increase Longevity and Healthspan in Companion Animals: Navigating the Boundary Between Protections for Animal Research and Human Subjects Research
- Ethical Considerations for Unblinding a Participant’s Assignment to Interpret a Resolved Adverse Event
- Shrinking Poor White Life Spans and the Requirements of Justice
- More Risky Than Radical
- 32 Shades of Neuroethics—A Review of the Routledge Handbook of Neuroethics, edited by L. Syd M Johnson and Karen S. Rommelfanger1
- Expanding a Shared Benefit Approach in One Health Research
- Racism and the Health of White Americans
- When Denial Hurts the Children: An Argument for Accountability of Denial in Parental Decision Making
- Denial and Dyads: Patients Whose Surrogates and Physicians Are Unrealistically Optimistic
- Getting Off the Leash
- Policing Compliance: Digital Medicine and Criminal Justice-Involved Persons
- Response to Open Peer Commentaries on ‘‘In Defense of ‘Denial’: Difficulty Knowing When Beliefs Are Unrealistic and Whether Unrealistic Beliefs Are Bad”
- Surveillance and Digital Health
- Adherence, Surveillance, and Technological Hubris
- Digital Medicine: An Opportunity to Revisit the Role of Bioethicists
- “I Know I’m Going to Beat This”: When Patients and Doctors Disagree About Prognosis
- “I Know I’m Going to Beat This”: When Patients and Doctors Disagree About Prognosis
- Resisting the Digital Medicine Panopticon: Toward a Bioethics of the Oppressed
- Digital Medicine, Cybersecurity, and Ethics: An Uneasy Relationship
- In Defense of “Denial”: Difficulty Knowing When Beliefs Are Unrealistic and Whether Unrealistic Beliefs Are Bad
- Digital Medicine and Ethics: Rooting for Evidence
- The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine
- Uterus Transplantation: Response to Open Peer Commentaries on the Ethics of Using Deceased Versus Living Donors
- Dependence on Digital Medicine in Resource-Limited Settings
- Smart Pills for Psychosis: The Tricky Ethical Challenges of Digital Medicine for Serious Mental Illness
- Propositions and Pragmatics
- Hope, Denial, and Third-Party Effects
- Review of Lori A. Roscoe and David Schenck, Communication and Bioethics at the End of Life: Real Cases, Real Dilemmas
- Surveillance Medicine in the DigitalEra: Lessons From Addiction Treatment
- Why (Some) Unrealistic Optimism is Permissible in Patient Decision Making
- We Convey More Than We (Literally) Say
- Response to Open Peer Commentaries on ‘‘Provider Conscientious Refusal of Abortion, Obstetrical Emergencies, and Criminal Homicide Law’’
- The Unintended Consequences of Reframing Denial, Unrealistic Optimism, and Self-Deception
- Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial
- In Defense of Common Human Responses
- Off-Target Effects of a Defense of Denial
- Not All Disagreements Are Treatment Refusals: The Need for New Paradigms for Considering Parental Treatment Requests
- Evaluating the Harm Principle and the Best Interest of the Child: A Case Resolved Using Standard Microeconomics Principles
- The “Reasonable Subject Standard” as an Alternative to the “Best Interest Standard”
- Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research
- The Best Interest Standard and the Child’s Right to an Open Future
- Ethical Management of Diagnostic Uncertainty: Response to Open Peer Commentaries on “Why Bioethics Should Be Concerned With Medically Unexplained Symptoms”
- Why the Best Interest Standard Is Not Self-Defeating, Too Individualistic, Unknowable, Vague or Subjective
- The Best Interest Standard: An Exhaustive Guide for Medical Decision Making in Pediatrics?
- Can Clinicians Be Objective? Inherent Challenges in Using Decision-Making Tools in Cases of Entrenched Disagreements
- In Defense of Best Interests: When Parents and Clinicians Disagree
- Best Interest, Harm, God’s Will, Parental Discretion, or Utility
- The Best Interests Standard as a Logic of Empire: Unpacking the Political Dimensions of Parental Refusal
- Keep It Simple
- Agreed: The Harm Principle Cannot Replace the Best Interest Standard … but the Best Interest Standard Cannot Replace The Harm Principle Either
- Reasons Don’t Matter
- The Best Interest Standard for Health Care Decision Making: Definition and Defense
- Ethical Complexity and Precaution When Parents and Doctors Disagree About Treatment
- Rumors of the Best Interest Standard’s Demise Have Been Greatly Exaggerated, and the Harm Principle Remains Tenuous: Responding to My Commentators
- The Value of Open Deliberation in Clinical Ethics, and the Role of Parents’ Reasons in the Zone of Parental Discretion
- When Parents Refuse: Resolving Entrenched Disagreements Between Parents and Clinicians in Situations of Uncertainty and Complexity
- The Harm Principle Cannot Replace the Best Interest Standard: Problems With Using the Harm Principle for Medical Decision Making for Children
- Prologomena to Any Future Pediatric Bioethics
- Pediatric Decision Making Requires Both Guidance and Intervention Principles
- Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies
- The Harm Principle and the Best Interests Standard: Are Aspirational or Minimal Standards the Key?
- Are Organ Donors Really Dead: The Near-Irrelevance of Autoresuscitation
- Reconsidering Refusal: Are Some Cases Refractory Even to the Best Tools?
- Best Interests or Harm to Reverse Parental Decisions: Each in Its Own Domain
- Being a Doctor and Being a Hospital
- Deceased Donation in Uterus Transplantation Trials: Novelty, Consent, and Surrogate Decision Making
- The Bioethical and Legal Implications of HHS’s New Focus on Conscience and Religious Freedom
- “Whole Again”: Why Are Penile Transplants Less Controversial Than Uterine?
- Duty to Warn in the Era of Next Generation Sequencing
- Conscience as a Civil and Criminal Defense
- Blanket Bans on Therapeutic Abortion and the Responsibilities of Hospitals as Moral Communities
- How Do You Donate Life When People Are Not Dying: Transplants in the Age of Autonomous Vehicles
- Challenges of Obesity Treatment: The Question of Decisional Capacity
- Allocating Uterus Transplants—Who Gets to Be a Gestational Mother?
- Living Donation, Listing, and Prioritization in Uterus Transplantation
- Uterus Transplantation: A Step Too Far
- A Woman in Full
- Forced Calorie Restrictions in the Clinical Setting
- Experience and Ethics at the “Cutting Edge”: Lessons From Maternal–Fetal Surgery for Uterine Transplantation
- Complex Obesity: Multifactorial Etiologies and Multifaceted Responses
- Provider Conscientious Refusal, Medical Malpractice, and the Right to Civil Recourse
- Is There a Duty to Warn Parents of a Cancer-Causing Genetic Mutation?
- UTx With Deceased Donors Also Places Risks and Burdens on Third Parties
- Response to Open Peer Commentaries on “Performance-Enhancing Drugs, Sport, and the Ideal of Natural Athletic Performance”
- Obesity, Pressure Ulcers, and Family Enablers
- The Purported Procurement Priority of Lifesaving Organs Over Non-Lifesaving Organs: Uterus Transplants and the Ethical Importance of Potential Lives
- Conscientious Refusal of Abortion in Emergency Life-Threatening Circumstances and Contested Judgments of Conscience
- Pregnant Women and Equitable Access to Emergency Medical Care
- Conscience Clauses: Too Much Protection for Providers, Too Little for Patients
- Enforcing Conscientious Objection to Abortion in Medical Emergency Circumstances: Criminal and Unethical
- Disclosure of Genetic Risk: When Genetic Relatives Are Not Family Members
- Assessing Duty to Warn in Donated Embryos
- Provider Conscientious Refusal of Abortion, Obstetrical Emergencies, and Criminal Homicide Law
- Toward the Ethical Allocation of Uterine Transplants
- Accommodating Conscience Without Curtailing Women’s Rights, Health, and Lives
- Treating Infertility with Transplantation: Theological views on whether Infertility is a Disease
- “A Little ELF, Please?” The Electronic Long-Form COI Disclosure Statement (ELFCOI)
- On Gender and Reproductive Decision-Making in Uterine Transplantation
- Uterus Transplantation: The Ethics of Using Deceased Versus Living Donors
- Review of David Benatar, The Human Predicament: A Candid Guide to Life’s Biggest Questions
- Getting the Story Straight: Clinical Ethics as a Distinctive Field
- Review of Eric Plemons, The Look of a Woman: Facial Feminization Surgery and the Aims of Trans-Medicine
- Goals Change Roles: How Does the Clinic Redefine Philosophical “Critical Distance”?
- Where’s the Merit in That? Limits to Employing the Natural in Antidoping Ethics
- Genetically Enhanced Minors: Whose Responsibility?
- An Alternative Account of Clinical Ethics: Leveraging the Strength of the Health Care Team
- Optimized or Hijacked? The Moral Boundaries of Natural Athletic Performance
- Effort? Natural Talent? More on the Normative Structure of Sport
- “Natural” Athletic Performance or a Level Playing Field? You Can’t Have Both
- Natural Talent, Fair Equality of Opportunity, and Therapeutic Use Exemptions
- Philosophers’ Invasion of Clinical Ethics: Historical and Personal Reflections
- Responsibility, Inefficiency, and the Spirit of Sport
- Ethics Consultation: Critical Distance/Clinical Competence
- Demythologizing Bioethics: The American Monomyth in Clinical Ethics Consultations
- Outside/Inside/Outside
- A Road Oft Traveled: Stumbling Into Clinical Ethics
- Wuz You Robbed? Concerns With Using Big Data Analytics in Sports
- Performance-Enhancing Drugs and Moral Line Drawing
- Exploring Clinical Ethics’ Past to Imagine Its Possible Future(s)
- Does Professional Objectivity Require Clinical Ethicists to Be Neutral?
- Were the “Pioneer” Clinical Ethics Consultants “Outsiders”? For Them, Was “Critical Distance” That Critical?
- Performance-Enhancing Drugs, Sport, and the Ideal of Natural Athletic Performance
- Where Have All the Theologians Gone and Should We Lament Their Passing?
- Reflections of a ‘Pioneer’: A Somewhat Different Path
- “Natural” Talents and Dedication—Meanings and Values in Sport
- White Privilege and Playing It Safe
- Outsider/Insider